KR920010296B1 - 위장암의 체외 진단방법 - Google Patents

위장암의 체외 진단방법 Download PDF

Info

Publication number
KR920010296B1
KR920010296B1 KR1019860700115A KR860700115A KR920010296B1 KR 920010296 B1 KR920010296 B1 KR 920010296B1 KR 1019860700115 A KR1019860700115 A KR 1019860700115A KR 860700115 A KR860700115 A KR 860700115A KR 920010296 B1 KR920010296 B1 KR 920010296B1
Authority
KR
South Korea
Prior art keywords
antibody
lima
sima
fragment
sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
KR1019860700115A
Other languages
English (en)
Korean (ko)
Other versions
KR860700154A (ko
Inventor
월리암 린넨 안토니
Original Assignee
뮤칸 다이어그노스틱스 피티와이. 리미티드
에취. 씨. 바라스
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 뮤칸 다이어그노스틱스 피티와이. 리미티드, 에취. 씨. 바라스 filed Critical 뮤칸 다이어그노스틱스 피티와이. 리미티드
Publication of KR860700154A publication Critical patent/KR860700154A/ko
Application granted granted Critical
Publication of KR920010296B1 publication Critical patent/KR920010296B1/ko
Expired legal-status Critical Current

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5753—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the stomach or small intestine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3046—Stomach, Intestines
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/813—Cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Investigating Or Analyzing Materials By The Use Of Fluid Adsorption Or Reactions (AREA)
  • Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)
KR1019860700115A 1984-06-25 1985-06-21 위장암의 체외 진단방법 Expired KR920010296B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPG5672 1984-06-25
AUPG567284 1984-06-25
PCT/AU1985/000136 WO1986000414A1 (en) 1984-06-25 1985-06-21 In vitro detection of gastrointestinal cancer

Publications (2)

Publication Number Publication Date
KR860700154A KR860700154A (ko) 1986-03-31
KR920010296B1 true KR920010296B1 (ko) 1992-11-21

Family

ID=3770652

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019860700115A Expired KR920010296B1 (ko) 1984-06-25 1985-06-21 위장암의 체외 진단방법

Country Status (15)

Country Link
US (2) US4818682A (enExample)
EP (1) EP0190159B1 (enExample)
JP (1) JP2520107B2 (enExample)
KR (1) KR920010296B1 (enExample)
CN (1) CN1034976C (enExample)
AT (1) ATE80470T1 (enExample)
AU (1) AU596075B2 (enExample)
CA (1) CA1263598A (enExample)
DK (1) DK170005B1 (enExample)
ES (1) ES8703023A1 (enExample)
GR (1) GR851540B (enExample)
NZ (1) NZ212419A (enExample)
PH (1) PH23387A (enExample)
WO (1) WO1986000414A1 (enExample)
ZA (1) ZA854700B (enExample)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5160723A (en) * 1985-04-19 1992-11-03 Sloan-Kettering Institute For Cancer Research Method of imaging colorectal carcinoma lesion and composition for use therein
ES8800604A1 (es) * 1985-04-22 1987-11-16 Hybritech Inc Un metodo para producir anticuerpos monoclonales
US5552291A (en) * 1985-10-09 1996-09-03 Kyowa, Hakko Kogyo Co., Ltd. Anti-human pulmonary adenocarcinoma specific monoclonal antibody
JPH0673470B2 (ja) * 1986-07-15 1994-09-21 協和醗酵工業株式会社 抗ヒト胃癌単クロ−ン性抗体ａｍｃ−４６２
JP2519038B2 (ja) * 1986-07-29 1996-07-31 郁男 山科 単クロ―ン抗体及びその製造方法
NZ222509A (en) * 1986-11-19 1993-03-26 Oncogen Hybridoma cell line producing antibodies binding to tumour-associated mucin antigen
US6004761A (en) * 1986-11-19 1999-12-21 Sanofi Method for detecting cancer using monoclonal antibodies to new mucin epitopes
JP2688824B2 (ja) * 1987-05-29 1997-12-10 郁男 山科 単クローン抗体ｎｋｙ１３
US5073493A (en) * 1987-05-29 1991-12-17 Ikuo Yamashina Monoclonal antibody nky13
US5075218A (en) * 1987-12-29 1991-12-24 Biomira, Inc. Screening for antibodies which bind carbohydrate epitopes of tumor-associated antigens, and uses thereof
US4921789A (en) * 1988-04-20 1990-05-01 New England Deaconess Hospital Corporation Marker for colorectal carcinoma and methods of detecting the same
US5292667A (en) * 1988-06-29 1994-03-08 The General Hospital Corporation Detection and treatment of ulcerative colitis
WO1990012892A1 (en) * 1989-04-14 1990-11-01 The Regents Of The University Of California Human intestinal mucin
DE69029270T2 (de) * 1989-09-15 1997-03-27 Genetic Systems Corp., Seattle, Wash. HYBRIDOMA CT43, DAS EIN ANTIKöRPER GEGEN EIN MUCINEPITOP VON DARMKREBS ERZEUGT
US5110911A (en) * 1989-11-02 1992-05-05 Biomira, Inc. Human tumor-associated thomsen-friedenreich antigen
US5242799A (en) * 1989-11-02 1993-09-07 Biomira, Inc. Lectin-antibody immunoassays for TF epitope-bearing antigens
WO1991008217A1 (en) * 1989-12-05 1991-06-13 The Regents Of The University Of California Human intestinal mucins
US5256540A (en) * 1990-12-28 1993-10-26 Mayo Foundation For Medical Education And Research Immunoassay for small cell lung carcinoma
US5245017A (en) * 1991-05-31 1993-09-14 Applied Biotechnology, Inc. Method for isolating CEA-binding protein
US5278290A (en) * 1991-05-31 1994-01-11 Applied Biotechnology, Inc. Binding protein for CEA and uses thereof
US5281697A (en) * 1991-05-31 1994-01-25 Applied Biotechnology, Inc. CEA-binding protein and uses thereof
EP0556496A3 (en) * 1992-02-21 1993-12-29 Dev Ct Biotechnology Antibodies against tumor-associated mucin glycoprotein
WO1995013831A1 (en) * 1993-11-17 1995-05-26 The Schepens Eye Research Institute, Inc. Antibody to ocular and vaginal surface epithelium
US5416025A (en) * 1993-11-29 1995-05-16 Krepinsky; Jiri J. Screening test for early detection of colorectal cancer
US5498608A (en) * 1994-01-07 1996-03-12 Salix Pharmaceuticals Use of 2-hydroxy-5-phenylazobenzoic acid derivatives as colon cancer chemopreventative and chemotherapeutic agents
CA2253093A1 (en) 1998-11-06 2000-05-06 Jiri J. Krepinsky Screening test for early detection of colorectal cancer
SE0004532D0 (sv) * 2000-12-07 2000-12-07 Caldwell Karin Dahlgren Use of mucin
EP1585960A2 (en) * 2002-01-14 2005-10-19 Vertex Pharmaceuticals Incorporated Mucin immobilized chromatography
ITTO20121154A1 (it) * 2012-12-27 2014-06-28 Fond Istituto Italiano Di Tecnologia Sistema di sonde per rivelare una sequenza nucleotidica bersaglio a singolo filamento

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4277437A (en) * 1978-04-05 1981-07-07 Syva Company Kit for carrying out chemically induced fluorescence immunoassay
DE3485733D1 (de) * 1983-01-21 1992-06-25 Frederick James Primus Spezifische antigene der cea(karzyno-embryonales-antigen)familie, spezifische antikoerper und verfahren zu ihrer verwendung.
US4579827A (en) * 1983-03-11 1986-04-01 Sloan-Kettering Institute For Cancer Research Monoclonal antibodies to human gastrointestinal cancers and hybridoma method of production of the monoclonal antibodies

Also Published As

Publication number Publication date
JPS61502701A (ja) 1986-11-20
DK170005B1 (da) 1995-04-24
NZ212419A (en) 1988-08-30
US5008184A (en) 1991-04-16
CN1034976C (zh) 1997-05-21
EP0190159A4 (en) 1988-08-04
ES544483A0 (es) 1987-01-16
KR860700154A (ko) 1986-03-31
JP2520107B2 (ja) 1996-07-31
CN85105430A (zh) 1987-05-13
EP0190159B1 (en) 1992-09-09
GR851540B (enExample) 1985-11-25
DK88086A (da) 1986-02-25
ES8703023A1 (es) 1987-01-16
AU4499685A (en) 1986-01-24
EP0190159A1 (en) 1986-08-13
DK88086D0 (da) 1986-02-25
ZA854700B (en) 1986-02-26
CA1263598A (en) 1989-12-05
US4818682A (en) 1989-04-04
AU596075B2 (en) 1990-04-26
ATE80470T1 (de) 1992-09-15
WO1986000414A1 (en) 1986-01-16
PH23387A (en) 1989-07-26

Similar Documents

Publication Publication Date Title
KR920010296B1 (ko) 위장암의 체외 진단방법
US4471057A (en) Detection of colorectal carcinoma
US4914021A (en) Carcinoma orosomucoid-related antigen, a monoclonal antibody thereto, and their uses
CA1339095C (en) Purification of cancer-associated protein and preparation of antibody thereto
US5646002A (en) Method for increasing the sensitivity of assays for target ligand
Konstadoulakis et al. The presence of anti-carcinoembryonic antigen (CEA) antibodies in the sera of patients with gastrointestinal malignancies
Buchegger et al. Monoclonal antibodies against carcinoembryonic antigen (CEA) used in a solid-phase enzyme immunoassay. First clinical results
JPH11315100A (ja) モノ特異性抗ｃｅａモノクロ―ナル抗体
EP0200464A2 (en) A tumor associated antigen
JP2000515854A (ja) 脳タンパク質ｓ―１００の存在の測定方法
AU601379B2 (en) Antigen indicative of human breast cancer and assays based thereon
JPS59501519A (ja) 炭水化物抗原決定基のための免疫検定
JP2915530B2 (ja) ラミニン フラグメント
EP0242727B1 (en) Method of assaying adenocarcinoma antigens
DE3586628T2 (de) In vitro-nachweis von gastrointestinalem krebs.
EP0140242A1 (en) Method for assaying basic fetoprotein and reagent therefor
NO860676L (no) Fremgangsm¨te og middel for in vitro p¨visning av cancer.
US5241052A (en) Carcinoma orosomucoid-related antigen, a monoclonal antibody thereto, and their uses
US5204450A (en) Carcinoma orosomucoid-related antigen, a monoclonal antibody thereto, and their uses
US5179000A (en) Method for assaying basic fetoprotein in urine and assay kit therefor
JPH08208698A (ja) モノクローナル抗体
Anthony et al. Measurement of carcinoembryonic antigen in serum of patients by using a technique of passive hemagglutination inhibition
CN119716066A (zh) 一种用于检测胃癌标志物的elisa试剂盒及其应用
EP0339632A2 (en) Method of assaying human cancer antigens
Tsuji et al. Detection of the circulating lung cancer marker LCAP with a new monoclonal antibody TRD-L1

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

G160 Decision to publish patent application
PG1605 Publication of application before grant of patent

St.27 status event code: A-2-2-Q10-Q13-nap-PG1605

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 7

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 8

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 9

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 10

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 11

FPAY Annual fee payment

Payment date: 20031106

Year of fee payment: 12

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 12

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20041122

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20041122

P22-X000 Classification modified

St.27 status event code: A-4-4-P10-P22-nap-X000

P22-X000 Classification modified

St.27 status event code: A-4-4-P10-P22-nap-X000